Blog post -

Heuristics of Design – John Sjölund’s talk at the IDF Congress in Dubai

The CEO of Timesulin, John Sjölund, was invited to deliver a presentation on the heuristics of design at the IDF’s World Diabetes Congress in December 2011. His talk focused on patient-led design and how these principles were engaged to create Timesulin – a simple product that addresses a global daily need, but which requires no change in the users’ habits, doesn’t need to be programmed and is affordable.

Watch the full presentation here:

Topics

  • Diseases

Categories

  • diabetes
  • diabetes conference
  • diabetic
  • diabetics
  • insulin pen
  • insulin reminder
  • insulin replacement cap
  • smart cap
  • john sjolund
  • insulin smart cap
  • idf
  • international diabetes federation
  • world diabetes congress
  • living with diabetes
  • life with diabetes

Contacts

Marie Rönn

Press contact Marketing Manager Account Management and Marketing +46 (0) 733 311 722

John Sjölund

Press contact CEO & Co-founder Sales and distribution, company spokesperson +44 (0)20 3287 2760 Timesulin Spokespeople

Related media

  • Timesulin: Insulin pen reminder 'smart caps'
  • License: Media Use
    The content may be downloaded by journalists, bloggers, columnists, creators of public opinion, etc. It can be used and shared in different media channels to convey, narrate, and comment on your press releases, posts, or information, provided that the content is unmodified. The author or creator shall be attributed to the extent and in the manner required by good practice (this means, for example, that photographers should be attributed).
  • By: Timesulin / www.timesulin.com
Download
  • Timesulin smart cap for Sanofi-Aventis Solostar
  • License: Media Use
    The content may be downloaded by journalists, bloggers, columnists, creators of public opinion, etc. It can be used and shared in different media channels to convey, narrate, and comment on your press releases, posts, or information, provided that the content is unmodified. The author or creator shall be attributed to the extent and in the manner required by good practice (this means, for example, that photographers should be attributed).
  • By: Timesulin / www.timesulin.com
Download
  • Timesulin smart cap for Novo Nordisk Flexpen
  • License: Media Use
    The content may be downloaded by journalists, bloggers, columnists, creators of public opinion, etc. It can be used and shared in different media channels to convey, narrate, and comment on your press releases, posts, or information, provided that the content is unmodified. The author or creator shall be attributed to the extent and in the manner required by good practice (this means, for example, that photographers should be attributed).
  • By: Timesulin / www.timesulin.com
Download
  • Timesulin smart cap for Lilly Kwikpen
  • License: Media Use
    The content may be downloaded by journalists, bloggers, columnists, creators of public opinion, etc. It can be used and shared in different media channels to convey, narrate, and comment on your press releases, posts, or information, provided that the content is unmodified. The author or creator shall be attributed to the extent and in the manner required by good practice (this means, for example, that photographers should be attributed).
  • By: Timesulin / www.timesulin.com
Download
Timesulin Fact Sheet
  • Timesulin Fact Sheet
  • License: Media Use
    The content may be downloaded by journalists, bloggers, columnists, creators of public opinion, etc. It can be used and shared in different media channels to convey, narrate, and comment on your press releases, posts, or information, provided that the content is unmodified. The author or creator shall be attributed to the extent and in the manner required by good practice (this means, for example, that photographers should be attributed).
  • File format: .pdf
Download

Related content

New Smart Cap ‘Timesulin’ Offers Major Advance in Diabetes Compliance

Innovative solution that shows insulin-dependent patients how long it’s been since their last injection, launches to consumers across Europe today.

Timely relief for insulin-dependent people with diabetes showcasing at global diabetes congress

A new product in the management of insulin-dependent diabetes, launching to consumers in Europe in January 2012, offers patients significant relief through an incorporated timer that tells them how long it’s been since their last insulin injection.